SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?


To: JoeinIowa who wrote (1493)3/7/2003 11:00:51 AM
From: Sergio H  Read Replies (1) | Respond to of 23958
 
Joe, DWYR gapped up this morning on 600 share volume in response to a pretty good earnings report. Yeehaw! My type of stock. Due to the low vol. technical studies are not of much value here.

SURE suffered from over reaction to news yesterday. It's a great opportunity for new position once this dust settles.

STOR is selling for a fraction of its cash. If they stop doing business right now and you buy the stock, you get almost 1.50 for every dollar or almost a 50% return. This is cash and not illiquid assets, so its not hard to imagine why someone would consider buying this co. out. Mathematically speaking, it should work out fine buying this stock now and waiting for someone else to pay closer to what its worth later.

AIQ on the other hand is heavily burdened with debt and has a majority shareholder very interested in converting the co's cash generation ability into cash. However AIQ is still a negative equation and the co. has yet to prove that it can balance its books. I don't see a reason to buy this stock right now.

The above is just my opinion, as usual, and is not intended to be the final word. On the contrary, discussion is welcome regardless if it is in agreement or disagreement with my opinion.



To: JoeinIowa who wrote (1493)3/9/2003 11:39:07 AM
From: JoeinIowa  Read Replies (1) | Respond to of 23958
 
Could be a interesting week for TRIB. They start a road show for investors on Monday. Latest research report raises 12 month target to $2.75. May not seem like that big of move from $1.90 but in todays market that is starting to look better all the time. Here is the latest report. May also be some news this week on their HIV test submittal.

jmdutton.com